Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) Net Margin (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Net Margin data on record, last reported at 9.74% in Q4 2025.

  • For Q4 2025, Net Margin rose 871.0% year-over-year to 9.74%; the TTM value through Dec 2025 reached 7.79%, up 818.0%, while the annual FY2025 figure was 4.99%, 925.0% up from the prior year.
  • Net Margin reached 9.74% in Q4 2025 per PAHC's latest filing, down from 9.97% in the prior quarter.
  • Across five years, Net Margin topped out at 11.2% in Q1 2022 and bottomed at 10.0% in Q2 2024.
  • Average Net Margin over 5 years is 3.82%, with a median of 4.47% recorded in 2023.
  • Peak YoY movement for Net Margin: surged 3584bps in 2021, then crashed -872bps in 2024.
  • A 5-year view of Net Margin shows it stood at 10.11% in 2021, then plummeted by -71bps to 2.95% in 2022, then tumbled by -83bps to 0.51% in 2023, then surged by 102bps to 1.03% in 2024, then surged by 846bps to 9.74% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 9.74% in Q4 2025, 9.97% in Q3 2025, and 5.42% in Q2 2025.